Key result
Angiotensin-converting enzyme 2 is discussed as a new cardiac regulator within the renin-angiotensin system.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
ACE2's role as cardiac regulator merits targeted studies; leaves open any clinical translation or practice change.
The renin–angiotensin system is a master regulator of human physiology. It controls blood pressure and fluid and electrolyte balance through coordinated effects on the heart, blood vessels, and kidneys. In the classic pathway of the renin–angiotensin system, renin is secreted from the juxtaglomerular apparatus of the kidney and acts on the circulating precursor angiotensinogen to generate angiotensin I (Figure 1). Angiotensin I has little effect on blood pressure and is converted in the lungs by angiotensin-converting enzyme (ACE) to angiotensin II. A potent vasopressor, angiotensin II acts on the heart and the kidneys by binding to the G protein–coupled receptors . . .
No takes yet. Share an insight, caveat, or question.
Boehm et al. (2002) reported a review. Angiotensin-converting enzyme 2 is discussed as a new cardiac regulator within the renin-angiotensin system.
Synapse has enriched 10 related papers. Consider them for comparative context: